lidoflazine has been researched along with Vertigo in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "During 6 months lidoflazine was applied ambulatorily in a dosage of 240 mg/a day orally in 21 patients after finished infarction." | 1.26 | [Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease]. ( Lukesch, KH; Schäbitz, J; Schmeisser, M; Teichmann, W; Vogel, HC, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teichmann, W | 1 |
| Vogel, HC | 1 |
| Schäbitz, J | 1 |
| Schmeisser, M | 1 |
| Lukesch, KH | 1 |
1 other study available for lidoflazine and Vertigo
| Article | Year |
|---|---|
[Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease].
Topics: Animals; Blood Pressure; Chronic Disease; Coronary Disease; Dogs; Drug Evaluation; Drug Tolerance; E | 1976 |